Videos

How to Prepare for Self-Advocacy After a Cancer Diagnosis

June 11th 2025, 1:00pm

Video

Patients can prepare for self-advocacy by bringing personal overviews to help care teams connect with them as individuals, explained Michelle Kirschner.

Enhertu Combo May Offer Longer Control for HER2+ Breast Cancer

June 10th 2025, 8:00pm

Video

Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.

Expanding on a New Way to Manage Polycythemia Vera Without Iron Deficiency

June 10th 2025, 1:00pm

Video

The VERIFY trial explores rusfertide to manage polycythemia vera without causing iron deficiency symptoms, Dr. Aaron Gerds explained.

You Are Not Alone While Building a Support Team During Cancer Care

June 9th 2025, 8:00pm

Video

Michelle Kirschner discusses the how patients can foster a strong network of supporters from diagnosis through survivorship.

Protect Your Healing by Lowering Chemical Exposure After Cancer Diagnosis

June 9th 2025, 1:28pm

Video

It is important to understand why it is vital that patients and survivors of cancer take steps to reduce the body’s burden both before and after treatment.

Sasanlimab-BCG Combo May Delay Recurrence in Bladder Cancer

June 6th 2025, 8:00pm

Video

Adding subcutaneous sasanlimab to BCG improved recurrence-free survival in non–muscle-invasive bladder cancer, according to Dr. Petros Grivas.

Understanding Supportive Care Needs in Younger Women With Cancer

June 5th 2025, 8:00pm

Video

Natalie Schnaitmann discusses urgent supportive care gaps younger women with cancer encounter, and how they affect long-term quality of life.

New or Persistent Acid Reflux May Signal Esophageal Cancer Risk

June 4th 2025, 8:00pm

Video

New or persistent acid reflux, especially after age 50, may mean higher risk for esophageal cancer, particularly in people with other known risk factors.

Targeting ESR1 Mutations Early May Improve Outcomes in Breast Cancer

June 3rd 2025, 8:00pm

Video

Dr. Massimo Cristofanilli discusses the early use of camizestrant with a CDK4/6 inhibitor to target ESR1 mutations, as it may improve outcomes in metastatic breast cancer.

Understanding the Side Effects of RLY-2608 in HR+, HER2– Breast Cancer

June 2nd 2025, 9:00pm

Video

Dr. Sarah Sammons discusses side effects associated with RLY-2608, and how it effects patients with HR-positive, HER2-negative advanced breast cancer.